Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery (ePPOP-ID)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02924636|
Recruitment Status : Recruiting
First Posted : October 5, 2016
Last Update Posted : July 7, 2020
|Condition or disease||Intervention/treatment||Phase|
|Obesity Pregnancy||Behavioral: ePPOP-ID program||Not Applicable|
Our study is an open, multicenter, randomized, parallel-group, controlled trial. This study will include obese pregnant women recruited in 11 French university hospitals. Patients will be randomized into two-parallel groups. One group underwent the electronic-personalized program (the interventional group) and the other underwent standard care (the control group). Due to the intervention by itself, a blind study would not be achievable.
Intervention group (the electronic-personalized program) The intervention will be presented as a comprehensive dietary and lifestyle intervention called "e-PPOP-ID" (electronic Personalized Programmed for Obesity in Pregnancy to Improve Delivery), including a combination of dietary, exercise, and behavioral strategies delivered on a web site.
The intervention will start at the latest by 20 weeks of pregnancy throughout the pregnancy and 8 weeks post-partum.
Pregnant women of the intervention group will be given an access to a personalized patient centric e-health platform. The platform we be specifically designed for this program. Various modules of this platform will be activated:
- An e-learning program: An e-Learning module will propose personalized content to each patient. Before the program, patients have to fill in questionnaires about food consumption (FFQ), Eating behavior (TFEQ) and physical activity (IPAQ). The answers of these questionnaires will be taken into account to define the e-learning lessons that patients must follow.Multi educational supports such as videos, fact sheets, quiz will be integrated into this program. Patient will be motivated to validate their program thanks to a reward system (access to new content by earning stars) and their knowledge can be estimated thanks to a quiz system.
Dieticians and adapted physical education teachers will develop the content.These lessons will include nutritional needs, motivational and behavioral advices, recipes, and movies of exercises easily achievable. The objective e-learning program is to limit weight gain by encouraging to healthy balance of carbohydrates, fat, protein, reducing high-energy foods intake (refined carbohydrates and saturated fats), increasing intake of fruits and vegetables and also by encouraging to physical activity. A second evaluation at around the 30th gestational weeks will allow adapting the lessons of the e-learning program, according to the progress of patients.
A Social network:
The platform will propose various social networking tools that can link the patient together or link the patient with the care team. Using a pseudo, patient will be able to connect together and interact with various tools such as a secured instant message system, a secured videoconference and a forum.
Motivation concepts Pregnant women will receive emails, which will encourage them to log in website and follow an e-learning lessons.A newsletter will be sent every month and will link to the new contents of the web site.Adhesion of program will be measured monthly by self-questionnaire of satisfaction and by measuring the time spent on the website including the forum.
Control group (Standard care):
The control group will receive standard care with oral information about the goal of nutritional needs during pregnancy and gestational weight gain guidelines according to BMI.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||860 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery - ePPOP Study|
|Actual Study Start Date :||November 13, 2017|
|Estimated Primary Completion Date :||November 2023|
|Estimated Study Completion Date :||November 2023|
personalized and online intervention. The intervention website will provide secure communication with dietician and lifestyle coaches. Women will receive emails and monthly newsletters with new content and reminder.
Behavioral: ePPOP-ID program
This is a personalized and online program. The website will provide secure communication with dietician and lifestyle coaches.
No Intervention: Control
standard care with oral information about the goal of nutritional needs during pregnancy and gestational weight gain guidelines according to BMI
- rate of obstetrical interventions [ Time Frame: at birth ]Caesarean section and instrumental delivery (forceps and vacuum extractor)
- Total gestational weight gain [ Time Frame: at birth ]
- Gestational hypertension [ Time Frame: at birth ]blood pressure > 140 and/or 90 mmHg after 20 weeks
- Preeclampsia [ Time Frame: at birth ]gestational hypertension and proteinuria = 0.30 g/24 h
- Gestational diabetes mellitus [ Time Frame: at birth ]Diagnosed by a 75g-oral glucose tolerance test (OGTT) between 24 and 28 according to French guidelines and International Association diabetic and Pregnancy Study Group
- Premature birth [ Time Frame: at birth ]
- gestational age [ Time Frame: at birth ]
- Birth weight [ Time Frame: at birth ]
- Apgar score [ Time Frame: at birth ]
- Arterial umbilical cord pH [ Time Frame: at birth ]
- Neonatal traumatism [ Time Frame: at birth ]composite outcome (shoulder dystocia + fracture + brachial plexus injury)
- Hyperbilirubinemia [ Time Frame: 1st week after birth ]
- Neonatal respiratory distress syndrome [ Time Frame: 1st week after birth ]
- Transfer in neonatal intensive care unit [ Time Frame: 1st week after birth ]
- Maternal fever [ Time Frame: 1st week after delivery ]
- Thromboembolic event [ Time Frame: 1st week after delivery ]
- Hemorrhage [ Time Frame: 1st week after delivery ]
- Breastfeeding duration [ Time Frame: 8 weeks +/- 2 weeks after delivery ]
- Maternal weight [ Time Frame: 8 weeks +/- 2 weeks after delivery ]
- child weight [ Time Frame: 8 weeks +/- 2 weeks after delivery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02924636
|Contact: Philippe Deruelle, MD,PhD||+33 320446307 ext +firstname.lastname@example.org|
|Contact: Sylvie Deghilage 0320446467 email@example.com|
|Principal Investigator: Sandy Hanssens, MD|
|Principal Investigator:||Philippe Deruelle, MD, PhD||University Hospital, Lille|